WARN Act Layoffs in San Diego, Arizona

Analysis: Layoffs in San Diego, Arizona

# Economic Analysis of Layoffs in San Diego, Arizona

Overview: Scale and Significance of Workforce Reductions

San Diego, Arizona has experienced minimal but concentrated layoff activity according to WARN filing data, with only two notices affecting 161 workers in the tracked period. While this represents a relatively small absolute number, the layoffs reflect deeper patterns in Arizona's tech and manufacturing sectors. The data spans from 2019 to 2024, revealing a five-year gap between notices that suggests either stable employment in this locality or underreporting during intervening years. For context, Arizona's insured unemployment rate stands at 0.56% as of early April 2026, well below the national insured rate of 1.25%, indicating that San Diego operates within a relatively tight labor market. However, the state's jobless claims have surged 105.3% year-over-year and 59.3% over the prior four-week period, signaling emerging labor market stress that may precede additional workforce reductions.

Dominant Employers and Drivers of Workforce Reductions

Dexcom, a leading continuous glucose monitoring manufacturer, dominates the San Diego layoff landscape with a single WARN notice affecting 160 workers—a reduction representing 99.4% of all affected workers in the city. This action reveals significant vulnerability in what is ostensibly a high-growth medical device sector. Dexcom filed its notice in 2024, suggesting recent operational challenges or strategic restructuring. The company's massive single-site reduction indicates either a consolidated manufacturing facility or a regional headquarters experiencing substantial contraction.

Bionano Genomics, meanwhile, filed the second notice affecting just one worker, likely representing a senior executive departure or a small targeted reduction in its San Diego operations. These two employers reveal that San Diego's layoff activity concentrates heavily in life sciences and medical device manufacturing—sectors that have faced significant headwinds from reimbursement pressures, supply chain normalization post-pandemic, and intensifying competition.

The dominance of Dexcom in this layoff data is particularly noteworthy given that the company has positioned itself as a growth engine in continuous monitoring technology. Such a substantial reduction suggests either margin compression in competitive markets, inventory correction, or a strategic pivot away from San Diego manufacturing operations.

Industry Patterns and Structural Forces

Manufacturing accounts for all 161 affected workers across both WARN notices, representing 100% of documented layoffs in San Diego during this period. This concentration reveals that the city's employment base remains anchored in traditional manufacturing rather than service, technology, or logistics sectors. The manufacturing focus aligns with Arizona's historical industrial base, though it contrasts with broader national trends favoring service-sector employment.

The structural forces driving these reductions likely include several converging pressures. First, medical device manufacturing faces persistent margin compression as healthcare payors continue demanding price concessions and demonstrating resistance to premium pricing for incremental innovation. Second, supply chain normalization has reduced the demand for manufacturing capacity that expanded during pandemic-driven logistics disruptions. Third, automation advancement in medical device production creates pressure to consolidate operations and reduce headcount in lower-value manufacturing tasks. The five-year gap between the 2019 and 2024 notices suggests that San Diego may have avoided major restructuring during the post-pandemic period, but 2024's activity indicates that deferral period has ended.

Historical Trends: Volatility and Recent Acceleration

The temporal distribution of WARN notices reveals an unstable employment picture. A single notice in 2019 affected an unknown number of workers before a complete absence of filings through 2023. The return of layoff activity in 2024 with Dexcom's massive reduction suggests that San Diego may be entering a new phase of labor market adjustment. The five-year gap may reflect either genuine employment stability or potential administrative gaps in WARN reporting.

Arizona's broader labor statistics support a narrative of emerging instability. While the state's unemployment rate sits at 4.5% as of January 2026, initial jobless claims have nearly doubled year-over-year, rising from 1,957 to 4,018 in the most recent week. This divergence between unemployment rates and claims trends typically signals accelerating layoff activity that has not yet fully reflected in unemployment statistics—a lag phenomenon driven by claims processing delays and workers transitioning through job search phases. The four-week trend showing claims rising from 2,523 to 4,018 (a 59.3% increase) suggests San Diego and Arizona more broadly should expect additional WARN filings in coming months.

Local Economic Impact and Community Effects

The loss of 160 jobs at Dexcom represents a substantial shock to San Diego's local economy, equivalent to eliminating the entire workforce of a mid-sized manufacturing facility. These positions likely carried above-average wages typical of medical device manufacturing, where production technicians, engineers, and quality specialists command $18-28 hourly rates plus benefits. The aggregate annual wage impact potentially exceeds $3 million in lost compensation, multiplied through reduced local spending at retail, food service, and entertainment venues.

The concentration of both notices in life sciences reflects San Diego's positioning as a regional biotech and medical device hub. However, the absence of high-employment-density layoffs in software, business services, or other sectors that dominate Arizona's major metros suggests San Diego's economy may be less exposed to the tech sector retrenchment visible in larger Arizona cities. This creates a paradoxical vulnerability: the city's reliance on manufacturing means a single large employer's restructuring creates outsized local impact, yet the smaller overall tech presence may spare it from the broader sector-wide contraction affecting Phoenix and Scottsdale.

Workers displaced from Dexcom will likely face moderate challenges redeploying their skills. Manufacturing technicians and quality specialists can transition to other medical device, semiconductor fabrication, or aerospace manufacturing roles, but San Diego's industrial base is smaller than Phoenix's, potentially requiring geographic relocation. The state's 4.5% unemployment rate suggests job availability, though wage replacement may prove challenging if workers cannot access comparable medical device roles.

Regional Context: San Diego Within Arizona's Labor Market

San Diego represents a small portion of Arizona's total employment and layoff activity. Arizona's H-1B certified petition data reveals that tech and computer occupations dominate visa-sponsored hiring across the state, with 55,865 certified H-1B/LCA petitions from 6,895 unique employers. Computer Systems Analysts alone account for 5,266 petitions at an average salary of $74,168, while Software Developers command salaries averaging $220,691 across 2,987 petitions.

Yet San Diego's WARN data shows zero participation in this tech visa hiring ecosystem. This disconnect highlights that San Diego functions as a manufacturing and medical device cluster rather than a software development or business services hub. The top H-1B employers—Infosys Limited, Tata Consultancy Services, and American Express—maintain minimal documented presence in San Diego based on WARN filings, suggesting their Arizona operations concentrate in Phoenix, Scottsdale, and Tempe.

This geographic mismatch creates distinct labor market dynamics. While Phoenix's tech sector faces potential visa-dependent workforce reductions if H-1B sponsorship tightens or companies reassess offshore labor arbitrage, San Diego's reliance on domestic manufacturing employment means local job availability depends more heavily on industrial production cycles and capital investment decisions by companies like Dexcom.

H-1B and Foreign Worker Hiring Context

The available H-1B data does not indicate simultaneous hiring and domestic layoffs at Dexcom or Bionano Genomics, as neither company appears in the Arizona H-1B petition records provided. This suggests San Diego's medical device manufacturers do not rely heavily on visa-sponsored talent, instead recruiting from domestic labor pools for manufacturing and technical roles. This contrasts sharply with Arizona's major tech employers, which collectively sponsor thousands of H-1B workers at salary levels often 20-40% below domestic market rates for equivalent positions.

The absence of H-1B utilization in San Diego's documented layoff companies may reflect the nature of medical device manufacturing roles—production technician and quality engineer positions typically require domestic regulatory certifications and FDA familiarity that employers prefer to source domestically. However, this also suggests that if Dexcom had pursued labor cost reduction through visa-sponsored hiring, the 160-worker reduction might have been smaller or avoided entirely, raising implicit questions about whether domestic labor policy choices affected employment decisions.